EDWARD C. SPINDLER JR.,GREGORY CHARLES WILLIAMS,LORETTA M. ITRI,MING-YI HU
申请号：
BR112015009291
公开号：
BR112015009291A2
申请日:
2013.10.26
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract methods for controlling, maintaining, or reducing blood pressure, and / or for treating, preventing, or alleviating symptoms such as dyspnea, in a patient suffering from or susceptible to acute heart failure. The methods involve the administration of an effective amount of a pharmaceutical composition comprising a short acting dihydropyridine compound such as clevidipine. the pharmaceutical composition may be administered at an initial dose, and if blood pressure is not controlled or maintained within a target blood pressure range or reduced to within a target blood pressure range, the initial dose may be titrated to achieve a blood pressure within the target blood pressure range. the patient may have a systolic blood pressure of about 120 mmhg or above. Abstract Methods for the Control of Blood Pressure and Reduction of Dyspnea in Heart Failure. methods for controlling, maintaining or lowering blood pressure, and / or treating, preventing or alleviating symptoms such as dyspnea in a patient suffering or susceptible to acute heart failure. The methods involve administering an effective amount of a pharmaceutical composition comprising a short-term dihydropyridine compound such as clevidipine. the pharmaceutical composition may be administered at an initial dose, and if blood pressure is not controlled or maintained within a target blood pressure range or reduced within a target blood pressure range, the dose may be titrated to obtain a blood pressure within the target range of blood pressure. The patient may have a systolic blood pressure around 120 mmhg or above.abstract methods for controlling, maintaining, or reducing blood pressure, and/or for treating, preventing, or alleviating symptoms such as dyspnea, in a patient suffering from or susceptible to acute heart failure. the methods involve the administration of an effective amount of a pharmaceutical composition comprising a short acting dihydropyridine compound such as clevidipine. the pharmaceutical
